title: Favourable outcome of Streptococcus agalactiae prosthetic valve endocarditis after conservative treatment.
authors.forename: Francesco
authors.initials: F
authors.lastname: Cappelli
authors.forename: Francesca R
authors.initials: FR
authors.lastname: Ermini
authors.forename: Stefano
authors.initials: S
authors.lastname: Del Pace
authors.forename: Serena
authors.initials: S
authors.lastname: Micheli
authors.forename: Gian Franco
authors.initials: GF
authors.lastname: Gensini
mesh_terms: D000368:Aged; D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001021:Aortic Valve; D004697:Endocarditis, Bacterial / Q000188:drug therapy / Q000382:microbiology*; D005260:Female; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006801:Humans; D016459:Prosthesis-Related Infections / Q000188:drug therapy / Q000209:etiology*; D013290:Streptococcal Infections / Q000188:drug therapy / Q000209:etiology*; D013292:Streptococcus agalactiae; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000667:Ampicillin